Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Ubiquitin and proteasome pathways, Epigenetics and DNA Methylation, and Cancer, Hypoxia, and Metabolism.
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P
Fabrication, Evaluation, and Antioxidant Properties of Carrier-Free Curcumin Nanoparticles
Preparation of curcumin-loaded MPEG-PTMC nanoparticles: Physicochemical properties, antioxidant activity, and in vivo pharmacokinetic behavior
Preparation of carrier-free astaxanthin nanoparticles with improved antioxidant capacity
Period 2 Suppresses the Malignant Cellular Behaviors of Colorectal Cancer Through the Epithelial-Mesenchymal Transformation Process
<i>Candida albicans</i> disorder is associated with gastric carcinogenesis
Emerging roles of nucleotide metabolism in cancer development: progress and prospect
Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing
Application of natural products for inducing ferroptosis in tumor cells
miR-539 activates the SAPK/JNK signaling pathway to promote ferropotosis in colorectal cancer by directly targeting TIPE
Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
UHMK1 promotes gastric cancer progression through reprogramming nucleotide metabolism
Microbial Community Profiling Distinguishes Left-Sided and Right-Sided Colon Cancer
Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth
Dual‐Specificity Tyrosine Phosphorylation–Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression
RETRACTED: Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers
Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1
Author response: RETRACTED: Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers
RETRACTED ARTICLE: Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis
miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer
Targeting posttranslational modifications of RioK1 inhibits the progression of colorectal and gastric cancers
SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage
MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B
Abstract 4544: FBW7 induces S-phase arrest caused by DNA double strand breaks through targeting SOX9 for proteasomal degradation
Abstract 1957: Negative regulation of Sox9 by glycogen synthase kinase 3 beta phosphorylation and SCFFbw7-dependent ubiquitination in cancer
The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway
<i>Sox9</i> mediates Notch1-induced mesenchymal features in lung adenocarcinoma
Tumour-associated mutant p53 drives the Warburg effect
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis